Clinical Trials Browser

Phase 1/2 × Drug-Related Side Effects and Adverse Reactions × Dermatologic × Clear all

NCT06120712 2025-12-23

MIZAR-002

Phase 1/2 Completed

Melanoma, Drug-Related Side Effects and Adverse Reactions

NCT03638375 2023-12-12

ACTME

Phase 1/2 Unknown

Melanoma, Drug-Related Side Effects and Adverse Reactions